US EditionViatris Deadline: VTRS Investors with Losses in Excess of $100K Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit
- Rosen Law Firm notifies individuals who purchased Viatris Inc. Securities during the period starting early August 2024 through late February 2025 that a class action lawsuit has been initiated.
- The case arises from the unsuccessful FDA inspection of Viatris' Indore facility, where the defendants eventually informed investors, several months after beginning corrective actions, about official FDA communications that restricted the shipment of multiple products from the site.
- Defendants labeled the Warning Letter’s impact as a 'minor headwind' while allegedly concealing the full adverse financial effects, leading investors to buy securities at inflated prices.
- Purchasers of NASDAQ: VTRS securities during the Class Period may seek compensation through contingency fee arrangements without upfront fees, with the lead plaintiff deadline on June 3, 2025.
- Rosen Law Firm, ranked in the top four firms since 2013, has recovered hundreds of millions for investors and represents global shareholders in this securities class action.
42 Articles
42 Articles
DEADLINE TOMORROW: Berger Montague Advises Viatris (NASDAQ: VTRS) Investors to Inquire About a Securities Fraud Class Action by June 3, 2025
PHILADELPHIA, June 2, 2025 /PRNewswire/ -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against Viatris Inc. ("Viatris" or the "Company") (NASDAQ: VTRS) on behalf of purchasers of Viatris securities between August 8, 2024…
VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm
LOS ANGELES, June 2, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. ("Viatris" or "the Company") (NASDAQ: VTRS) for violations of §§10(b) and 20(a) of…
#Justice Awaits Viatris Investors Unite for Class Action Lawsuit,
The Law of the Land: Viatris Inc. Investors Urged to Stand Up for Justice In a striking turn of events, investors of Viatris Inc. (NASDAQ: VTRS) are being called to action as Bronstein, Gewirtz & Grossman LLC, a renowned law firm, initiates a class action lawsuit against the pharmaceutical company and its officers. This announcement on June 2, 2025, beckons those who have suffered substantial losses in their investments to join what promises to …
Coverage Details
Bias Distribution
- 64% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
